Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    et al. Nat. Biotechnol. 24, 1151–1161 (2006).

  2. 2.

    et al. Nat. Biotechnol. 28, 827–838 (2010).

  3. 3.

    et al. Nat. Biotechnol. 32, 903–914 (2014).

  4. 4.

    & Nature 483, 531–533 (2012).

  5. 5.

    Anonymous. Nat. Biotechnol. 30, 806 (2012).

  6. 6.

    & Nature 505, 612–613 (2014).

  7. 7.

    Science 343, 229 (2014).

  8. 8.

    Anonymous. Nat. Biotechnol. 33, 319 (2015).

  9. 9.

    et al. Science 348, 1420–1422 (2015).

  10. 10.

    et al. Science 348, 1422–1425 (2015).

  11. 11.

    Nature 533, 452–454 (2016).

  12. 12.

    & Nat. Biotechnol. 35, 342–346 (2017).

  13. 13.

    et al. Nat. Biotechnol. 35, 316–319 (2017).

  14. 14.

    et al. PLoS Med. 2, 0696–0701 (2005).

  15. 15.

    et al. Evolution of Translational Omics; Lessons Learned and the Path Forward. (National Academies Press, Washington, DC, 2012).

  16. 16.

    et al. Nat. Genet. 41, 149–155 (2009).

  17. 17.

    et al. Sci. Data. 3, 160018 (2016).

Download references

Acknowledgements

The first MAQC Society meeting was supported by the SAS Institute, Burroughs Wellcome Fund, and the National 863 Program of China (2015AA020104, to L.S.).

Author information

Affiliations

  1. State Key Laboratory of Genetic Engineering, School of Life Sciences and Shanghai Cancer Center, Fudan University, Shanghai, China.

    • Leming Shi
  2. Collaborative Innovation Center for Genetics and Development, Fudan University, Shanghai, China.

    • Leming Shi
  3. Immuneering Corporation, Cambridge, Massachusetts, USA.

    • Rebecca Kusko
  4. SAS Institute Inc., Cary, North Carolina, USA.

    • Russell D Wolfinger
  5. Princess Margaret Cancer Centre, Toronto, Ontario, Canada.

    • Benjamin Haibe-Kains
  6. Departments of Medical Biophysics and Computer Science, University of Toronto, Toronto, Ontario, Canada.

    • Benjamin Haibe-Kains
  7. Ontario Cancer Research Institute, Toronto, Ontario, Canada.

    • Benjamin Haibe-Kains
  8. Department of Experimental Pediatric Oncology, University Children's Hospital of Cologne, Medical Faculty, Cologne, Germany.

    • Matthias Fischer
  9. Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.

    • Matthias Fischer
  10. Oxford e-Research Centre, Engineering Science Department, University of Oxford, Oxford, UK.

    • Susanna-Assunta Sansone
  11. Weill Cornell Medicine, New York, New York, USA.

    • Christopher E Mason
  12. Fondazione Bruno Kessler, Trento, Italy.

    • Cesare Furlanello
  13. Q2 Solutions, Morrisville, North Carolina, USA.

    • Wendell D Jones
  14. National Center for Toxicological Research, US Food and Drug Administration, Jefferson, Arkansas, USA.

    • Baitang Ning
    •  & Weida Tong

Authors

  1. Search for Leming Shi in:

  2. Search for Rebecca Kusko in:

  3. Search for Russell D Wolfinger in:

  4. Search for Benjamin Haibe-Kains in:

  5. Search for Matthias Fischer in:

  6. Search for Susanna-Assunta Sansone in:

  7. Search for Christopher E Mason in:

  8. Search for Cesare Furlanello in:

  9. Search for Wendell D Jones in:

  10. Search for Baitang Ning in:

  11. Search for Weida Tong in:

Competing interests

R.K. is an employee of Immuneering Corporation. R.D.W is an employee of SAS Institute Inc., and W.D.J. is an employee of Q2 Solutions.

Corresponding author

Correspondence to Weida Tong.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nbt.4029

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing